Zacks.com on MSN1d
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in USPulmicort sales declined 4% to $138 million. Fasenra recorded sales of $436 million in the quarter, up 13% year over year, ...
Fiera Capital Corp trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback